1975
DOI: 10.1080/09553007514550351
|View full text |Cite
|
Sign up to set email alerts
|

The Lung-colony Assay: Extension to the Lewis Lung Tumour and the B16 Melanoma–Radiosensitivity of B16 Melanoma Cells

Abstract: Experiments are described which demonstrate that a lung-colony assay can be used to study the viability of unknown cell populations from the B16 Melanoma or the Lewis Lung Tumour. It is shown that the number of lung colonies formed can be increased by the addition of plastic microspheres to the injected cell suspension or by pre-irradiating the lungs of the recipient mice. The colony technique has been used to isolate melanotic and amelanotic cell-lines from the B16 Melanoma which were found to have different … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
16
0

Year Published

1977
1977
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 7 publications
2
16
0
Order By: Relevance
“…Cell survival provides an important alternative to tumour growth delay or tumour cure for assessing the response to treatment of tumours including xenografts, and provides a measure of cell kill that is uncorn-plicated by the effects of host response upon the tuimours. In addition to the present study of humaan melanoma xenografts, the success of cloning colonic, oatcell, uterine and ovarian carcinomas in diffusion chambers (Smith et al, 1976, 1978, andunpublished observations) The observation of exponential cellsurvival curves for melphalan and MeCCNU is in keeping with published work oni animal tumours (Valeriote & Tolen, 1972;Hill & Stanley, 1975) and in in vitro cell lines (Barlogie & Drewinko, 1977;Barranco et al, 1978). This result supports the hypothesis that greater therapeutic effect against a tumour may be anticipated when higher doses of these agents are used in man, providing that increased toxicity to the patient cani be circumvented or effectively treated (McElwain et al, 1979).…”
Section: Clonogentc Cell Survivalsupporting
confidence: 87%
“…Cell survival provides an important alternative to tumour growth delay or tumour cure for assessing the response to treatment of tumours including xenografts, and provides a measure of cell kill that is uncorn-plicated by the effects of host response upon the tuimours. In addition to the present study of humaan melanoma xenografts, the success of cloning colonic, oatcell, uterine and ovarian carcinomas in diffusion chambers (Smith et al, 1976, 1978, andunpublished observations) The observation of exponential cellsurvival curves for melphalan and MeCCNU is in keeping with published work oni animal tumours (Valeriote & Tolen, 1972;Hill & Stanley, 1975) and in in vitro cell lines (Barlogie & Drewinko, 1977;Barranco et al, 1978). This result supports the hypothesis that greater therapeutic effect against a tumour may be anticipated when higher doses of these agents are used in man, providing that increased toxicity to the patient cani be circumvented or effectively treated (McElwain et al, 1979).…”
Section: Clonogentc Cell Survivalsupporting
confidence: 87%
“…The pulmonary tumours were produced by injection into the tail vein of 0-2-ml aliquots of cell suspension each containing 104 viable tumour cells and 106 plastic microspheres (15 ,um diameter; 3M Company, Minneapolis, Minnesota). The technique was originally employed in the lung colony assay developed for this tumour (Hill and Stanley, 1975a) and yielded in each animal an average of 20 lung colonies which were clearly visible after 10 days growth. By allowing different periods of time to elapse between implantation and experiment, it was possible to vary the size of nodule available for study.…”
Section: Methodsmentioning
confidence: 99%
“…Tumours were assayed immediately after both types of irradiation treatment. Cell-suspension technique and cell-survival assay.-Single-cell suspensions of treated and control tumours were prepared by trypsin digestion as previously described, with volumes of reagents scaled down proportionately when pulmonary tumours were used (Hill and Stanley, 1975a).…”
Section: Methodsmentioning
confidence: 99%
“…injected cells has been used as a method of assaying the clonogenic capacity of cells removed from treated murine tumours. This approach was first described by Hill and Bush (1969) using the KHT sarcoma, and since that time it has been applied to a number of other mouse tumouirs including the C22LR osteosarcoma (van Putten et al, 1975) and the Lewis lung tumour and B 16 melanoma (Hill and Stanley, 1975). A high cloning efficiency in the lungs for i.v.…”
mentioning
confidence: 99%